|Print This Page Email to a Friend|
The University of South Alabama Board of Trustees has approved an agreement for increased collaboration between the USA Mitchell Cancer Institute and the University of Alabama at Birmingham Comprehensive Cancer Center.
The agreement is the next step in creating a consortium relationship between the two institutions. USA Mitchell Cancer Institute will partner with UAB in its 2020 application for the renewal of its five-year Cancer Center Support Grant from the National Institutes of Health. When the expected renewal is granted, the USA Mitchell Cancer Institute will share UAB's status as a National Cancer Institute-designated Comprehensive Cancer Center consortium partner. The designation is currently held by only 45 research-based cancer centers nationwide.
“By forging a consortium with an NCI-designated Comprehensive Cancer Center, we become part of an elite group,” said Dr. Michael Finan, director of USA Mitchell Cancer Institute. “This gives us an opportunity to showcase our level of research and to achieve greater success. This collaboration will ensure the highest quality of patient care and access to leading-edge clinical research for the citizens of Alabama and our neighboring states.”
USA Mitchell Cancer Institute and UAB Comprehensive Cancer Center are the only academic cancer research centers in Alabama. The UAB center has held the NCI designation since 1973.
(Above) USA Chairman of the Board Steven Furr signs an agreement to create a cancer consortium partnership with the University of Alabama at Birmingham as USA President Tony Waldrop, center, and MCI Director Michael Finan look on.
© 2017 USA Health System